Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

genetic puzzle pieces

A Genetic Origin of MS

MP3 WAV

  • In trying to understand why more Northern Europeans get MS, scientists are onto a clue that suggests that this genetic variant was selected to survive disease.  About a fifth of northern Europeans with MS have a genetic variant in a HLA gene associated with the immune system.  Carrying even one copy of it makes a person about three times more likely to develop MS. 

    To understand its origins, researchers traced gene variants in MS and found the gene in question among ancient peoples in parts of Eastern Europe and Western Asia. About 5,000 years ago, they migrated west into Northern Europe. There for some reason, these gene variants were passed on maybe because they provided greater survival or reproductive value. Since MS is an autoimmune disease, the overactive immune system may have helped fight off infectious diseases.  

    The change in lifestyle thousands of years ago from hunter-gatherer to farming along with environmental triggers may help us understand why MS has been more prevalent. MS is thought to be caused by gene to gene as well as environmental to- gene interactions.  Evidence has pointed to triggers such as viral infections in people genetically predisposed to MS.  With no cure, perhaps by looking into the past, we’ll find answers for a better future prognosis.

    We are Drs. David Niesel and Norbert Herzog, at UTMB and Quinnipiac University, where biomedical discoveries shape the future of medicine.   For much more and our disclaimer go to medicaldiscoverynews.com or subscribe to our podcast. Sign up for expanded print episodes at www.illuminascicom.com or our podcasts at:  Medical Discovery News (buzzsprout.com) 

More Information

Prehistoric events might explain European multiple sclerosis risk
An exploration of more than 1,600 ancient Eurasian genomes suggests that genetic changes that increase autoimmune-disease risk in modern Europeans could have protected ancient Europeans from pathogens.

DNA from ancient Europeans reveals surprising multiple sclerosis origins
DNA obtained from the bones and teeth of ancient Europeans who lived up to 34,000 years ago is providing insight into the origin of the often-disabling neurological disease multiple sclerosis, finding that genetic variants that now increase its risk once served to protect people from animal-borne diseases.

Ancient DNA Helps Solve Multiple Sclerosis Mystery in Europe
The secrets of our ancestors might hold the key to why multiple sclerosis (MS) is more common among white, northern Europeans than among Europe's more southern populations.

Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations
Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that is most prevalent in Northern Europe. Although it is known that inherited risk for MS is located within or in close proximity to immune-related genes, it is unknown when, where and how this genetic risk originated1. Here, by using a large ancient genome dataset from the Mesolithic period to the Bronze Age2, along with new Medieval and post-Medieval genomes, we show that the genetic risk for MS rose among pastoralists from the Pontic steppe and was brought into Europe by the Yamnaya-related migration approximately 5,000 years ago. 

Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Despite the breadth of the literature on the epidemiology of MS in Europe, inter-study comparisons are hampered by the lack of standardization. Further research should focus on regions not yet studied and the evaluation of ethnic differences in MS prevalence and incidence. 

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.